Wird geladen...
Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension
Objectives: Evidence has shown that angiotensin-converting enzyme 2 (ACE2), which can be upregulated after angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) treatment, may play a dual role in the pathogenesis and progression of coronavirus disease 2019 (COVID-19)....
Gespeichert in:
| Veröffentlicht in: | Front Cardiovasc Med |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8202940/ https://ncbi.nlm.nih.gov/pubmed/34136537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.577398 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|